Ticker: CUBI

Customers Bank

Finance Financials Banks - Regional

Price 86.41

Reco Buy Potential 79 Risk 35 Updated 2026-10-27

Official website

Forecast impact

positive

Target +24.5% target fill 80.3%

Reaction D5 pending · D10 pending fresh confirmed · market trust

Impact Potential +6 · Risk -3 valid until 2026-11-25

Track in portfolio

Price chart

AI recommendation Analyst forecast Calendar event Positive signal Negative signal Neutral / update Hold / informational B My buy S My sell

Description

Company and Business Model

Customers Bank operates in the financial sector, providing a range of banking services including commercial and consumer lending, deposit accounts, and treasury management. Its core products encompass loans, mortgages, and various deposit services. The bank primarily generates revenue through interest income from loans and fees associated with its banking services.

Investment Profile

The investment profile of Customers Bank is more aligned with value investors, given its current valuation metrics and market conditions. The stock may appeal to those seeking stability rather than aggressive growth, reflecting a cautious outlook on its performance.

Category: Finance Sector: Financials Industry: Banks - Regional Investment style: Balanced Horizon: Medium-term Company type: Mid Cap

Fundamental metrics (experimental) Updated: 2026-10-27

EPS (TTM) — earnings per share for the last 12 months, $: 8.54
Revenue QoQ — quarter-over-quarter revenue growth: 6.2%
EPS surprise: 6.1%
20d volatility: 1.9%

AI recommendation changes

Date	Before	After	Reason
2026-10-27	Hold	Buy	Strong momentum and solid EPS growth support bullish outlook.
2026-10-21	Sell	Hold	Weak revenue growth raises concerns despite positive EPS surprise.
2026-09-24	Hold	Sell	Weak momentum and fundamentals raise significant risk concerns.
2026-09-22	Sell	Hold	Mixed performance; revenue decline raises concerns.
2026-09-17	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-09-15	Sell	Hold	Weak revenue growth offsets positive EPS surprise.
2026-09-10	Buy	Sell	Weak fundamentals and negative momentum raise concerns.
2026-09-04	Sell	Buy	Mixed performance; monitor for clearer signals.
2026-09-02	Hold	Sell	Weak fundamentals and negative momentum raise concerns.
2026-08-18	Buy	Hold	Weak revenue growth raises concerns despite positive EPS surprise.
2026-07-28	Hold	Buy	Strong momentum and positive EPS surprise support growth outlook.
2026-07-17	Sell	Hold	Mixed performance; cautious due to revenue decline.
2026-07-09	Hold	Sell	Weak fundamentals and negative momentum raise significant risk.
2026-07-07	Buy	Hold	Mixed performance; cautious outlook amid revenue decline.
2026-06-29	Hold	Buy	Strong momentum but revenue decline raises concerns.
2026-06-21	Buy	Hold	Weak revenue growth raises caution despite solid EPS.
2026-06-11	Hold	Buy	Mixed signals; monitor fundamentals and market conditions.
2026-05-20	Sell	Hold	Weak revenue growth offsets solid EPS performance.
2026-05-12	Buy	Sell	Weak revenue and negative momentum raise concerns.
2026-05-08	—	Buy	Mixed fundamentals; cautious momentum signals present.
2026-05-06	Hold	Buy	Компания показывает умеренный рост за последние 120 дней, однако снижение выручки в квартальном выражении вызывает опасения. Рекомендуется удерживать акции до получения более ясных сигналов о восстановлении доходов.
2026-04-28	—	Hold	Компания показывает положительную динамику за последние 20 и 120 дней, несмотря на недавнее снижение выручки. Учитывая высокий EPS и умеренный риск, инвестиции в CUBI могут быть оправданы.

Analyst forecasts

Date	Analyst	Action	Target	Price Then
2026-10-26	D.A. Davidson	Target Raised	— → 107	85.545
2026-10-26	Morgan Stanley	Target Raised	89 → 97	86.61
2026-10-26	Piper Sandler	Target Raised	92 → 102	84.54
2026-09-08	Morgan Stanley	Rating Downgraded	— → 89	81.07
2026-07-27	D.A. Davidson	Target Raised	— → 100	78.4
2026-07-01	Fundamental Research	Target Raised	86 → 94	79.1
2026-06-29	Morgan Stanley	Target Raised	83 → 88	79.55
2026-06-26	Piper Sandler	Target Raised	86 → 92	79.45
2026-04-27	D.A. Davidson	Target Raised	91 → 93	76.75
2026-04-27	Piper Sandler	Target Raised	82 → 86	74.38
2026-02-06	Stephens	Rating Downgraded	— → 71	76.7
2026-01-26	D.A. Davidson	Target Raised	93 → 95	76.91
2026-01-26	Maxim Group	Target Raised	95 → 100	76.885
2026-01-06	Raymond James	Target Raised	— → 95	76.18
2025-12-08	Morgan Stanley	Update	— → 90	70.95
2025-10-28	Stephens	Target Raised	62 → 68	68.29

News Page 1 of 1

Nothing yet